170 related articles for article (PubMed ID: 21835316)
41. Clinical implications of the BARI 2D and COURAGE trials: overview.
Brooks MM; Boden WE; Frye RL
Coron Artery Dis; 2010 Nov; 21(7):383-5. PubMed ID: 20664331
[TBL] [Abstract][Full Text] [Related]
42. Contemporary percutaneous coronary intervention versus balloon angioplasty for multivessel coronary artery disease: a comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (BARI) study.
Srinivas VS; Brooks MM; Detre KM; King SB; Jacobs AK; Johnston J; Williams DO
Circulation; 2002 Sep; 106(13):1627-33. PubMed ID: 12270854
[TBL] [Abstract][Full Text] [Related]
43. Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial.
Bittner V; Bertolet M; Barraza Felix R; Farkouh ME; Goldberg S; Ramanathan KB; Redmon JB; Sperling L; Rutter MK;
J Am Coll Cardiol; 2015 Aug; 66(7):765-773. PubMed ID: 26271057
[TBL] [Abstract][Full Text] [Related]
44. SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial.
Ikeno F; Brooks MM; Nakagawa K; Kim MK; Kaneda H; Mitsutake Y; Vlachos HA; Schwartz L; Frye RL; Kelsey SF; Waseda K; Hlatky MA;
J Am Coll Cardiol; 2017 Jan; 69(4):395-403. PubMed ID: 28126156
[TBL] [Abstract][Full Text] [Related]
45. [The BARI 2D study].
Mafrici A; Briguori C
G Ital Cardiol (Rome); 2010 Oct; 11(10):711-7. PubMed ID: 21246772
[No Abstract] [Full Text] [Related]
46. Impact of completeness of revascularization on long-term cardiovascular outcomes in patients with type 2 diabetes mellitus: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D).
Schwartz L; Bertolet M; Feit F; Fuentes F; Sako EY; Toosi MS; Davidson CJ; Ikeno F; King SB
Circ Cardiovasc Interv; 2012 Apr; 5(2):166-73. PubMed ID: 22496082
[TBL] [Abstract][Full Text] [Related]
47. Letter by Liu et al regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial".
Liu W; Chen M; Huang DJ
Circulation; 2014 Apr; 129(16):e459. PubMed ID: 24753556
[No Abstract] [Full Text] [Related]
48. Contemporary practice of coronary revascularization in U.S. hospitals and hospitals participating in the bypass angioplasty revascularization investigation (BARI).
Detre KM; Rosen AD; Bost JE; Cooper ME; Sutton-Tyrrell K; Holubkov R; Shemin RJ; Frye RL
J Am Coll Cardiol; 1996 Sep; 28(3):609-15. PubMed ID: 8772747
[TBL] [Abstract][Full Text] [Related]
49. Appropriate revascularization in stable angina: lessons from the BARI 2D trial.
Krone RJ; Althouse AD; Tamis-Holland J; Venkitachalam L; Campos A; Forker A; Jacobs AK; Ocampo S; Steiner G; Fuentes F; Pena Sing IR; Brooks MM;
Can J Cardiol; 2014 Dec; 30(12):1595-601. PubMed ID: 25475464
[TBL] [Abstract][Full Text] [Related]
50. Do Clinical Outcomes and Quality of Life Differ by the Number of Antianginals for Stable Ischemic Heart Disease? Insights from the BARI 2D Trial.
Jamil Y; Park DY; Verde LM; Sherwood MW; Tehrani BN; Batchelor WB; Frampton J; Damluji AA; Nanna MG
Am J Cardiol; 2024 Mar; 214():66-76. PubMed ID: 38160927
[TBL] [Abstract][Full Text] [Related]
51. Change in enrollment patterns, patient selection, and clinical outcomes with the availability of drug-eluting stents in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
Shah B; Srinivas VS; Lu J; Brooks MM; Bates ER; Nedeljkovic ZS; Escobedo J; Das GS; Lopez JJ; Feit F
Am Heart J; 2013 Sep; 166(3):519-26. PubMed ID: 24016502
[TBL] [Abstract][Full Text] [Related]
52. Coronary artery bypass in patients with type 2 diabetes: experience from the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
Sako EY; Brooks MM; Hardison RM; Schaff H; Frye RL
J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1268-72. PubMed ID: 24507404
[TBL] [Abstract][Full Text] [Related]
53. Asymptomatic Cardiac Ischemia Pilot (ACIP) study: effects of coronary angioplasty and coronary artery bypass graft surgery on recurrent angina and ischemia. The ACIP investigators.
Bourassa MG; Pepine CJ; Forman SA; Rogers WJ; Dyrda I; Stone PH; Chaitman BR; Sharaf B; Mahmarian J; Davies RF
J Am Coll Cardiol; 1995 Sep; 26(3):606-14. PubMed ID: 7642849
[TBL] [Abstract][Full Text] [Related]
54. Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.
Rezende PC; Hueb W; Garzillo CL; Lima EG; Hueb AC; Ramires JA; Kalil Filho R
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1105-12. PubMed ID: 22944095
[TBL] [Abstract][Full Text] [Related]
55. Effect of age in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial.
Mullany CJ; Mock MB; Brooks MM; Kelsey SF; Keller NM; Sutton-Tyrrell K; Detre KM; Frye RL
Ann Thorac Surg; 1999 Feb; 67(2):396-403. PubMed ID: 10197660
[TBL] [Abstract][Full Text] [Related]
56. Impact of diabetes and early revascularization on the need for late and repeat procedures.
Orbach A; Halon DA; Jaffe R; Rubinshtein R; Karkabi B; Flugelman MY; Zafrir B
Cardiovasc Diabetol; 2018 Feb; 17(1):25. PubMed ID: 29402330
[TBL] [Abstract][Full Text] [Related]
57. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
[TBL] [Abstract][Full Text] [Related]
58. Clinical implications of the BARI 2D and COURAGE trials of coronary artery disease.
Kuller LH
Coron Artery Dis; 2010 Nov; 21(7):391-6. PubMed ID: 20634693
[TBL] [Abstract][Full Text] [Related]
59. Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy. Results from the Bypass Angioplasty Revascularization Investigation (BARI).
Berger PB; Velianou JL; Aslanidou Vlachos H; Feit F; Jacobs AK; Faxon DP; Attubato M; Keller N; Stadius ML; Weiner BH; Williams DO; Detre KM;
J Am Coll Cardiol; 2001 Nov; 38(5):1440-9. PubMed ID: 11691521
[TBL] [Abstract][Full Text] [Related]
60. Burgeoning dilemmas in the management of diabetes and cardiovascular disease: rationale for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
Sobel BE; Frye R; Detre KM;
Circulation; 2003 Feb; 107(4):636-42. PubMed ID: 12566379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
